Introduction: COVID-19 sequelae are numerous and multisystemic, and how to evaluate those symptomatic patients is a timely issue. Klok proposed the Post-COVID-19 Functional Status (PCFS) Scale as an easy tool to evaluate limitations related to persistent symptoms. Our aim was to analyse PCFS Scale ability to detect functional limitations and its correlation with quality of life in a cohort of patients, 2-9 months after hospitalisation for COVID-19 hypoxemic pneumonia.

Methods: PCFS Scale was evaluated in 121 patients together with quality of life and dyspnoea questionnaires, pulmonary function tests and CT scans.

Results: We observed a high correlation with multiple questionnaires (Short Form-36, Hospital Anxiety and Depression Scale, modified Medical Research Council, end Borg Six-Minute Walk Test), making the PCFS Scale a quick and global tool to evaluate functional limitations related to various persistent symptoms following COVID-19 pneumonia.

Discussion: The PCFS Scale seems to be a suitable instrument to screen for patients who will require careful follow-up after COVID-19 hypoxemic pneumonia even in the absence of pulmonary sequelae.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915286PMC
http://dx.doi.org/10.1136/bmjresp-2021-001136DOI Listing

Publication Analysis

Top Keywords

pcfs scale
24
post-covid-19 functional
8
functional status
8
status pcfs
8
cohort patients
8
tool evaluate
8
limitations persistent
8
persistent symptoms
8
functional limitations
8
quality life
8

Similar Publications

Mobile application development to improve the active search for functional impairment and persistent symptoms in individuals post-COVID-19.

Semergen

December 2024

Departamento de Educação Integrada em Saúde, Universidade Federal do Espírito Santo, Vitória, ES, Brazil. Electronic address:

Objectives: This study aimed to develop a mobile application (App) to be used by primary care teams in the active search for functional impairment, long-term symptoms, and disabilities in individuals who have recovered from COVID-19, contributing to early treatment and referrals for multidisciplinary care and rehabilitation. This experimental study used the minimum viable product (MVP) methodology to develop an App named ReabilitaCOVID.

Methods: This methodology involves ideation, content creation, prototype creation, usability tests, and adjustments based on feedback.

View Article and Find Full Text PDF

Predictors of Functional Impairment in Severe COVID-19 Patients Two Months After Discharge.

Ther Adv Pulm Crit Care Med

December 2024

Department of Pulmonary and Critical Care Medicine, Hôtel-Dieu de France University, Medical Center (HDFUMC) of the Saint-Joseph University of Beirut (USJ), Beirut, Lebanon.

Background: The Post-COVID-19 Functional Status (PCFS) scale is a validated tool used to measure the functional status of patients discharged from the hospital.

Objectives: To describe the functional limitations of hospitalized COVID-19 patients at the time of discharge and two months afterward, and to identify risk factors associated with functional impairment.

Design: Retrospective study.

View Article and Find Full Text PDF
Article Synopsis
  • * The study compared postural balance in 60 adults (30 who recovered from COVID-19 and 30 healthy controls) using various assessments like the Functional Reach Test (FRT) and the Berg Balance Scale (BBS).
  • * Results showed significant balance differences, particularly with the FRT, and all balance tests correlated with functional status in the post-COVID-19 group, with the Tinetti Balance Test being the best predictor of functional status.
View Article and Find Full Text PDF

Background/aim: Symptoms of COVID-19 may persist for months. One of the persistent symptoms of COVID-19 is fatigue, which reduces functional status. The relationship between fatigue, functional status, and various other factors has received little attention, which this study aims to address.

View Article and Find Full Text PDF

In patients previously hospitalised for COVID-19, a 12-week high-intensity interval training (HIIT) intervention has previously been shown to increase left ventricular mass (LVM) immediately after the intervention. In the present study, we examined the effects of the same HIIT scheme on LVM, pulmonary diffusing capacity, symptom severity and functional capacity at 12-month follow-up. In this investigator-blinded, randomised controlled trial, 12 weeks of a supervised HIIT scheme (4 × 4 min, three times a week) was compared to standard care (control) in patients recently discharged from hospital due to COVID-19.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!